Literature DB >> 6801124

Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement.

A Sher, S Hieny, S L James, R Asofsky.   

Abstract

Laboratory mice with genetic or induced immunodeficiencies were vaccinated with irradiated cercariae of Schistosoma mansoni and assayed 4 wk later for their resistance to challenge infection. Athymic nude mice failed to develop immunity to challenge or detectable antibody responses to schistosomula, whereas heterozygote (nu/+) controls and nude mice with thymus grafts displayed highly significant levels of resistance and anti-schistosomulum antibody. Similarly, no resistance or antibody production as observed in vaccinated mice that had been made deficient in B lymphocytes by the injection of anti-mu-chain antisera from birth. In contrast, normal levels of vaccine-induced resistance were observed in mice genetically deficient in the fifth component of complement (C5) and in mice decomplemented before challenge by treatment with cobra venom factor. These results indicate that the resistance to challenge infection induced by irradiated cercariae is both thymus and B lymphocyte dependent and therefore is likely to result from specific immune responses directed against schistosome worms. The data also argue against a role for complement in the effector mechanism of vaccine-induced immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells.

Authors:  S Anderson; P S Coulson; S Ljubojevic; A P Mountford; R A Wilson
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

3.  Still hope for schistosomiasis vaccine.

Authors:  Alessandra Ricciardi; Momar Ndao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-kilorad doses: the 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge.

Authors:  S R Reynolds; D A Harn
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

5.  The role of antibody affinity and titre in immunity to Schistosoma mansoni following vaccination with highly irradiated cercariae.

Authors:  D A Vignali; M E Devey; Q D Bickle; M G Taylor
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

6.  A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.

Authors:  D A Vignali; P Crocker; Q D Bickle; S Cobbold; H Waldmann; M G Taylor
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

7.  The T-cell mediated immune response to Schistosoma mansoni. I. Generation of stage-specific, MHC-restricted proliferative T-cell clones to soluble egg antigens.

Authors:  N K Mak; C J Sanderson
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

8.  Activated macrophages as effector cells of protective immunity to schistosomiasis.

Authors:  S L James
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

9.  Immunity to schistosomiasis mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae: I. Humoral responses against skin-stage schistosomula.

Authors:  J R Gordon; D J McLaren
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

10.  Genetic complementation of defects in vaccine-induced immunity against Schistosoma mansoni in P- and A-strain inbred mice.

Authors:  R Correa-Oliveira; S L James; A Sher
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.